Trade GYRE stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Gyre Therapeutics, Inc. (GYRE) is trading at US$6.69, down 0.59% today as of Sep 14, 16:00 EDT. The company has a market capitalisation of US$732.69M. Over the past 52 weeks, GYRE has traded between US$5.44 and US$9.42. On Syfe you can trade GYRE with $0 commission and add it to your watchlist.
| Previous close | US$6.73 |
|---|---|
| Market cap | US$732.69M |
| 52-week range | US$5.44 – US$9.42 |
| Volume | 104.12K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Gyre Therapeutics, Inc.
Gyre Therapeutics, Inc. operates as a biopharmaceutical company. It is focused on the development and commercialization of small-molecule therapies for the treatment of organ fibrosis and inflammatory diseases. The firm operates two distinct segments: Gyre Pharmaceuticals and Gyre. The Gyre Pharmaceuticals segment extends three major commercial drug products including ETUARY, Etorel, and Contiva as well as several product candidates in preclinical and clinical development. The Gyre segment consists of the development and commercialization of Hydronidone for the treatment of metabolic dysfunction-associated steatohepatitis associated liver fibrosis. The company was founded on March 7, 1997 and is headquartered in San Diego, CA.
Year: 2023
Gyre Therapeutics Says China Regulator Accepts Application for Liver Fibrosis Drug
May 12, 9:53 PM · MT Newswires
-- Earnings Flash (GYRE) Gyre Therapeutics, Inc. Reports Q1 Revenue $22.5M, vs. FactSet Est of $31.6M
May 7, 10:12 AM · MT Newswires
--Earnings Flash (GYRE) Gyre Therapeutics Posts Q1 Loss $0.10 a Share, vs. FactSet Est of $0.07 Loss
May 7, 10:05 AM · MT Newswires
Gyre Therapeutics Completes $300 Million All-Stock Acquisition of Cullgen
May 4, 2:43 PM · MT Newswires
Gyre Therapeutics, Inc. (GYRE) stock is trading at US$6.69, -0.59% from the previous close of US$6.73.
The market cap for Gyre Therapeutics, Inc. (GYRE) stock is approximately US$732.69M.
The 52-week high for Gyre Therapeutics, Inc. (GYRE) stock is US$9.42.
The 52-week low for Gyre Therapeutics, Inc. (GYRE) stock is US$5.44.
Gyre Therapeutics, Inc. (GYRE) does not currently pay a dividend.
Stay on top of GYRE
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
